Barriers to Clinical Trial Efficiency: The Heart Failure Collaboratory Industry Experience

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Design of the GutHeart-targeting Gut Microbiota to Treat Heart Failure-Trial: A Phase II, Randomized Clinical Trial

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Hemodynamic Guided Therapy for Heart Failure: Initial Clinical Experience With the CardioMEMSTMHF System

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Estimating Clinical Morbidity Due to Ischemic Heart Disease and Congestive Heart Failure: The Future Rise of Heart Failure.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1994English

Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

How to Manage Heart Failure in the Modern Clinical Practice

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
2011English

Heart Failure Clinical Trials - Broadening the Definition of the Ideal Heart Failure Site Investigator

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Improving Patient Outcomes in Heart Failure: Evidence and Barriers

Heart
2000English

Barriers to Weight Loss in a Heart Failure With Preserved Ejection Fraction Clinic

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy